Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e. (Q30374687)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

influenza vaccine

1 reference

based on heuristic

inferred from title

Liudmila Tsybalova

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Nikolai V. Ravin

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Liudmila A Stepanova

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Victor V Kuprianov

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Elena A Blokhina

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Marina V Potapchuk

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Alexander V Korotkov

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Andrey N Gorshkov

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Marina A Kasyanenko

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Oleg I Kiselev

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

0 references

publication date

11 May 2015

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

33

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

3398-3406

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25976545%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Developing vaccines against pandemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Influenza virus M2 protein has ion channel activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Characterization of the murine Th2 response to immunization with liposomal M2e influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Immunogenicity and protective efficacy of candidate universal influenza A nanovaccines produced in plants by Tobacco mosaic virus-based vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

A "universal" human influenza A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Universal influenza A vaccine: optimization of M2-based constructs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

A molecular assembly system for presentation of antigens on the surface of HBc virus-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

The influence of antigen organization on B cell responsiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Universal vaccine against influenza virus: linking TLR signaling to anti-viral protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2015.04.073

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30374687&oldid=1639021047"